Alk-Abello AS (AKBLF)
24.60
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Alk-Abello Net Income (Quarterly): 29.01M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 29.01M |
| March 31, 2024 | 33.79M |
| December 31, 2023 | 20.20M |
| September 30, 2023 | 17.09M |
| June 30, 2023 | 9.646M |
| March 31, 2023 | 23.51M |
| December 31, 2022 | 10.72M |
| September 30, 2022 | 7.040M |
| June 30, 2022 | 6.013M |
| March 31, 2022 | 24.59M |
| December 31, 2021 | 11.69M |
| September 30, 2021 | 5.866M |
| June 30, 2021 | -3.403M |
| March 31, 2021 | 20.59M |
| December 31, 2020 | -4.966M |
| September 30, 2020 | -3.142M |
| June 30, 2020 | -1.477M |
| March 31, 2020 | 12.70M |
| December 31, 2019 | -1.927M |
| September 30, 2019 | -2.086M |
| June 30, 2019 | -10.23M |
| March 31, 2019 | 6.849M |
| December 31, 2018 | -22.32M |
| September 30, 2018 | -4.834M |
| June 30, 2018 | -2.724M |
| Date | Value |
|---|---|
| March 31, 2018 | 3.959M |
| December 31, 2017 | -25.16M |
| September 30, 2017 | -4.899M |
| June 30, 2017 | -0.1479M |
| March 31, 2017 | 0.2865M |
| December 31, 2016 | 5.220M |
| September 30, 2016 | 5.848M |
| June 30, 2016 | 10.93M |
| March 31, 2016 | 18.19M |
| December 31, 2015 | 20.38M |
| September 30, 2015 | 9.233M |
| June 30, 2015 | 7.996M |
| March 31, 2015 | 13.48M |
| December 31, 2014 | 2.685M |
| September 30, 2014 | 4.623M |
| June 30, 2014 | 5.697M |
| March 31, 2014 | 19.83M |
| December 31, 2013 | 7.299M |
| September 30, 2013 | 1.599M |
| June 30, 2013 | -5.255M |
| March 31, 2013 | 7.433M |
| December 31, 2012 | -2.608M |
| September 30, 2012 | 9.401M |
| June 30, 2012 | 22.10M |
| March 31, 2012 | 7.053M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-4.966M
Minimum
Dec 2020
33.79M
Maximum
Mar 2024
10.77M
Average
10.18M
Median
Net Income (Quarterly) Benchmarks
| Genmab AS | 203.24M |
| Ascendis Pharma AS | -117.77M |
| Galecto Inc | -5.338M |
| Evaxion Biotech AS | -6.198M |
| IO Biotech Inc | -20.69M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 198.33M |
| Total Expenses (Quarterly) | 160.22M |
| EPS Diluted (Quarterly) | 0.1299 |
| Enterprise Value | 5.412B |
| Gross Profit Margin (Quarterly) | 63.10% |
| Profit Margin (Quarterly) | 14.63% |
| Earnings Yield | 1.83% |
| Operating Earnings Yield | 2.40% |
| Normalized Earnings Yield | 1.828 |